<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ling X</submitter><funding>Guizhou University</funding><pagination>7795527</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8692010</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>2021</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Shu-Di-Huang (Radix Rehmanniae Praeparata, RR) and Gan-Cao (liquorice, L) are frequently used traditional Chinese herb pair in treating osteoporosis (OP). However, the exact mechanism of the RR and L herb pair (RR-L) remains unclear. To explore the efficacy and possible mechanisms of RR-L in treating OP, in silico, in vitro, and in vivo experiments were conducted in the current study.&lt;h4>Methods&lt;/h4>In silico, potential therapeutic target genes and active chemical compounds of RR-L herb pair were predicted and constructed into a network. In vivo, 30 Sprague Dawley rats were divided into 3 groups, including the sham group, the OP model group, and the RR-L-treated OP group. Micro-CT and pathological sections were conducted to validate the therapeutic effects of RR-L in tre</pubmed_abstract><journal>Evidence-based complementary and alternative medicine : eCAM</journal><pubmed_title>Shu-Di-Huang and Gan-Cao Herb Pair Restored the Differentiation Potentials of Mesenchymal Stem Progenitors in Treating Osteoporosis via Downregulation of NF-&lt;i>κ&lt;/i>B Signaling Pathway.</pubmed_title><pmcid>PMC8692010</pmcid><funding_grant_id>5766-02</funding_grant_id><pubmed_authors>Li J</pubmed_authors><pubmed_authors>Zhang T</pubmed_authors><pubmed_authors>Ling X</pubmed_authors><pubmed_authors>Wang X</pubmed_authors><pubmed_authors>Zhou Y</pubmed_authors><pubmed_authors>Kang J</pubmed_authors><pubmed_authors>Zhou X</pubmed_authors></additional><is_claimable>false</is_claimable><name>Shu-Di-Huang and Gan-Cao Herb Pair Restored the Differentiation Potentials of Mesenchymal Stem Progenitors in Treating Osteoporosis via Downregulation of NF-&lt;i>κ&lt;/i>B Signaling Pathway.</name><description>&lt;h4>Background&lt;/h4>Shu-Di-Huang (Radix Rehmanniae Praeparata, RR) and Gan-Cao (liquorice, L) are frequently used traditional Chinese herb pair in treating osteoporosis (OP). However, the exact mechanism of the RR and L herb pair (RR-L) remains unclear. To explore the efficacy and possible mechanisms of RR-L in treating OP, in silico, in vitro, and in vivo experiments were conducted in the current study.&lt;h4>Methods&lt;/h4>In silico, potential therapeutic target genes and active chemical compounds of RR-L herb pair were predicted and constructed into a network. In vivo, 30 Sprague Dawley rats were divided into 3 groups, including the sham group, the OP model group, and the RR-L-treated OP group. Micro-CT and pathological sections were conducted to validate the therapeutic effects of RR-L in tre</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021</publication><modification>2025-05-29T21:06:11.659Z</modification><creation>2025-05-29T21:06:11.659Z</creation></dates><accession>S-EPMC8692010</accession><cross_references><pubmed>34950216</pubmed><doi>10.1155/2021/7795527</doi></cross_references></HashMap>